Drug or chemical induced diabetes mellitus with diabetic arthropathy
ICD-10 E09.61 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with diabetic arthropathy.
E09.61 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of diabetic arthropathy. This condition arises when certain medications, such as glucocorticoids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. Diabetic arthropathy is a complication of diabetes that manifests as joint pain and stiffness due to the effects of prolonged hyperglycemia on joint tissues. Patients may experience symptoms such as swelling, limited range of motion, and increased risk of joint damage. Management of E09.61 involves controlling blood glucose levels through lifestyle modifications, monitoring HbA1c levels, and potentially using insulin or other antidiabetic medications. Regular assessments for diabetic complications, including arthropathy, are crucial for maintaining patient quality of life and preventing further morbidity.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes after starting corticosteroids.
Endocrinologists must ensure that the cause of diabetes is clearly documented to support the use of E09.61.
Assessment of joint symptoms, imaging studies, and treatment plans.
Patients with diabetes presenting with joint pain and stiffness.
Rheumatologists should document the relationship between diabetes and joint symptoms to justify coding E09.61.
Used for follow-up visits for diabetes management.
Document patient's medication list, HbA1c levels, and any complications.
Endocrinologists should ensure comprehensive diabetes management documentation.
Common medications that can induce diabetes include glucocorticoids, thiazide diuretics, and certain antipsychotics. It's important to monitor blood glucose levels in patients starting these medications.
